Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BIFIDOBACTERIUM SPP. EXPRESSING AND SECRETING DIABODY-TYPE BSAB
Document Type and Number:
WIPO Patent Application WO/2021/038975
Kind Code:
A1
Abstract:
A problem addressed by the present invention is to provide Bifidobacterium spp. that exert a persistent, specific antitumor effect on solid cancers. Bifidobacterium spp. that express a first polypeptide including a light chain variable region (VL) that binds to human CD3 and a heavy chain variable region (VH) that binds to a human tumor cell surface antigen and a second polypeptide including a VL that binds to a human tumor cell surface antigen and a VH that binds to human CD3, and secrete a diabody-type bispecific antibody constructed from the first polypeptide and the second polypeptide are produced.

Inventors:
SHIMATANI YUKO (JP)
KOBAYASHI SATOSHI (JP)
SHIOYA KOICHIRO (JP)
KATAOKA SHIRO (JP)
SEKI YUJI (JP)
MATSUMURA TOMIO (JP)
KANARI YASUYOSHI (JP)
UMETSU MITSUO (JP)
NAKAZAWA HIKARU (JP)
Application Number:
PCT/JP2020/019075
Publication Date:
March 04, 2021
Filing Date:
May 13, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ANAEROPHARMA SCIENCE INC (JP)
UNIV TOHOKU (JP)
International Classes:
A61K39/395; A61K31/7016; A61K35/745; A61K47/26; A61P35/00; A61P43/00; C07K16/46; C12N1/21; C12N15/13
Domestic Patent References:
WO2016088376A12016-06-09
WO2011078332A12011-06-30
WO2007029773A12007-03-15
WO2010109924A12010-09-30
WO2015146438A12015-10-01
WO2009128272A12009-10-22
WO2009128275A12009-10-22
WO2011093465A12011-08-04
WO2015166640A12015-11-05
WO2016088376A12016-06-09
WO2015146437A12015-10-01
WO2012147713A12012-11-01
WO2011093097A12011-08-04
WO2011062112A12011-05-26
WO2018062225A12018-04-05
Foreign References:
JP2004242638A2004-09-02
US6492123B12002-12-10
JP3803790B22006-08-02
JPS642755B21989-01-18
JP2009520734W
JP2008503449W
JP2013508391W
JP2017504314W
JP2018535972W
JP2012158534A2012-08-23
JP2013514793W
JP2010523096W
JP2013529061W
Other References:
ASANO, R. ET AL.: "Humanization of the bispecific epidermal growth factor receptor x CD 3 diabody and its efficacy as a potential clinical reagent", CLIN. CANCER RES., vol. 12, no. issue 13, 2006, pages 4036 - 4042, XP003017843, DOI: 10.1158/1078-0432.CCR-06-0059
ASANO, R. ET AL.: "Highly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabody", J. BIOL. CHEM., vol. 285, no. 27, 2010, pages 20844 - 20849, XP055110416, DOI: 10.1074/jbc.M110.120444
NAT REV DRUG DISCOV, 7 June 2019 (2019-06-07)
PROC NATL ACAD SCI U S A., no. 14, 15 July 1993 (1993-07-15), pages 6444 - 8
SCI REP, vol. 7, no. 1, 6 June 2017 (2017-06-06), pages 2862
YASUYUKI TAKAGI: "Procedure for Experiment in Genetic Engineering", 1982, COLD SPRING HARBOR LABORATORY
"Molecular/Cloning", 1989, COLD SPRING HARBOR LABORATORY
"Methods in Enzymology", vol. 194, 1991
THE MOLECULAR BIOLOGY SOCIETY OF JAPAN, 1994
J. MICROBIOLOGY, 2012, pages 638 - 643
J. BACTERIOLOGY, 2005, pages 5799 - 5808
BIOTECHNOL. LETT., vol. 30, 2008, pages 1983 - 1988
BIOTECHNOL. LETT., vol. 28, 2006, pages 163 - 168
APPL ENVIRON MICROBIOL., vol. 200672, no. 11, pages 7401 - 7405
CANCER GENE THER, vol. 200714, pages 151 - 157
J MICROBIOL BIOTECHNOL, vol. 22, no. 12, December 2012 (2012-12-01), pages 1714 - 23
J MICROBIOL, vol. 50, no. 4, August 2012 (2012-08-01), pages 638 - 43
JMICROBIOL, vol. 50, no. 4, August 2012 (2012-08-01), pages 638 - 43
BIOSCI BIOTECHNOL BIOCHEM., vol. 69, no. 2, February 2005 (2005-02-01), pages 422 - 5
LETT APPL MICROBIOL, vol. ll, no. 4, October 1990 (1990-10-01), pages 220 - 3
J MICROBIOL BIOTECHNOL, vol. 19, no. 4, April 2009 (2009-04-01), pages 403 - 8
APPL ENVIRON MICROBIOL, vol. 73, no. 24, December 2007 (2007-12-01), pages 7858 - 66
PLASMID, vol. 57, no. 2, March 2007 (2007-03-01), pages 165 - 74
APPL ENVIRON MICROBIOL, vol. 72, no. 1, January 2006 (2006-01-01), pages 527 - 35
MICROBIOLOGY, vol. 145, March 1999 (1999-03-01), pages 585 - 92
J. MICROBIOL BIOTECHNOL, vol. 22, no. 12, December 2012 (2012-12-01), pages 1714 - 23
Attorney, Agent or Firm:
HIROTA, Masanori (JP)
Download PDF: